BioKangtai's Inactivated COVID-19 Vaccine (Vero Cell) is Approved Homologous Booster Vaccination in China

Recently,the Joint Prevention and Control Mechanism of the State Council approved homologousbooster vaccination ofBioKangtai'sInactivated COVID-19Vaccine(VeroCell) in China.

This means that one dose of homologous booster vaccination in previous recipients of two doses of BioKangtai's Inactivated COVID-19 Vaccine (Vero Cell). The research shows that both homologous boostervaccination and sequential boostervaccination could further improve the immune effect. For the target population,either homologous boostervaccination or sequential boostervaccination could be selected. 

Source:

Shenzhen TV news:
https://mp.weixin.qq.com/s/wJpPwOhRdPPARFhcWq2nmQ 

Shenzhen Special ZoneDaily:
http://sztqb.sznews.com/PC/layout/202202/20/node_A03.html#content_1167067 

China’sNanfang Daily:

https://epaper.southcn.com/m/ipaper/nfrb/html/202202/20/content_10005449.html?from=weChatMessage